The FDA granted approval Oct. 27 for toripalimab-tpzi, a new drug therapy for head and neck cancer patients.
Read the full post on Becker's Hospital Review - Healthcare News
FDA approves new head and neck cancer drug
The FDA granted approval Oct. 27 for toripalimab-tpzi, a new drug therapy for head and neck cancer patients.
Read the full post on Becker's Hospital Review - Healthcare News